Nr566 Midterm |137 Questions| With Correct Answers.

Hyperlipidemia Diagnosis {Ans: Guidelines for identifying risk for CAD and CVD have traditionally focused on serum cholesterol levels above 200 mg/dL, fasting trigylceride TG levels above 150 mg/dL, and LDL levels above 100 mg/dL. The newest guidelines place a stronger emphasis upon individual risk factors with lifestyle and pharmacological therapies individualized to reduce that risk.}Improving patient compliance with diabetes treatment {Ans: Nonadherence to the treatment regimen may result in increased risk for complications and reduced life expectancy. Healthcare providers should be aware of potential problems with nonadherence, discuss the importance of adherence at each follow-up visit, and assist patients in removing barriers to adherence such as lack of social support and cost of the treatment regimen. A team approach with the patient as an active partner should be maximized. Ways to deal with nonadherence are discussed in Chapter 6. Patient education booklets are available from the ADA, which can be accessed on the Internet at www.diabetes.org.}Preferred antihypertensives for blacks {Ans: Calcium Channel Blockers}Asthma step therapy {Ans: The Expert Panel Report 3: Guidelines (NAEPP, 2007) recommends a stepwise approach to the pharmacological management of asthma. Management can begin at a higher level and gradually step down or